• Boehringer inks pact with Domain for GPCR neurology drugs fiercebiotech
    January 02, 2019
    French-Canadian biotech Domain Therapeutics has another big pharma partner, signing a deal with Germany’s Boehringer Ingelheim to develop new drugs for central nervous system (CNS) disorders....
PharmaSources Customer Service